The reduction of astrocytic tau prevents amyloid-β-induced synaptotoxicity.
The reduction of astrocytic tau prevents amyloid-β-induced synaptotoxicity.
复制标题
DOI:
10.1093/braincomms/fcac235
复制
发表时间:
2022
影响因子:
4.8
通讯作者:
中科院分区:
文献类型:
--
作者:
Alzheimer’s disease is a neurological disorder characterized by the overproduction and aggregation of amyloid-beta and the phosphorylation and intraneuronal accumulation of tau. These events promote synaptic dysfunction and loss, leading to neurodegeneration and cognitive deficits. Astrocytes are intimately associated with synapses and become activated under pathological conditions, becoming neurotoxic and detrimentally affecting synapses. Although it has been established that reducing neuronal tau expression prevents amyloid-beta-induced toxicity, the role of astrocytic tau in this setting remains understudied. Herein, we performed a series of astrocytic and neuronal primary cultures to evaluate the effects of decreasing astrocytic tau levels on astrocyte-mediated amyloid-beta-induced synaptic degeneration. Our results suggest that the downregulation of tau in astrocytes mitigates the loss of synapses triggered by their exposure to amyloid-beta. Additionally, the absence of tau from astrocytes promotes the upregulation of several synaptoprotective genes, followed by increased production of the neuroprotective factor Pentraxin 3. These results expand our understanding of the contribution of astrocytic tau to the neurodegenerative process induced by amyloid-beta-stimulation and how reducing astrocytic tau could improve astrocyte function by stimulating the expression of synaptoprotective factors. Reducing endogenous astrocytic tau expression could be a potential strategy to prevent synaptic damage in Alzheimer's disease and other neurological conditions. Cisternas et al. reported how the downregulation of tau in astrocytes mitigates the loss of synapses triggered by their exposure to amyloid-beta. The authors suggested that the absence of tau from astrocytes promotes the upregulation of a series of synaptoprotective genes such as Pentraxin 3.
登录
查看更多内容
影响因子:
4.3
作者:
DeVos SL;Corjuc BT;Oakley DH;Nobuhara CK;Bannon RN;Chase A;Commins C;Gonzalez JA;Dooley PM;Frosch MP;Hyman BT
通讯作者:
Hyman BT
影响因子:
16.6
作者:
Bi M;Gladbach A;van Eersel J;Ittner A;Przybyla M;van Hummel A;Chua SW;van der Hoven J;Lee WS;Müller J;Parmar J;Jonquieres GV;Stefen H;Guccione E;Fath T;Housley GD;Klugmann M;Ke YD;Ittner LM
通讯作者:
Ittner LM
影响因子:
14.8
作者:
Beaudoin, Gerard M. J., III;Lee, Seung-Hye;Arikkath, Jyothi
通讯作者:
Arikkath, Jyothi
影响因子:
5.3
作者:
DeVos, Sarah L.;Goncharoff, Dustin K.;Miller, Timothy M.
通讯作者:
Miller, Timothy M.
影响因子:
9
作者:
通讯作者:
--